1. Home
  2. DRCT vs AEMD Comparison

DRCT vs AEMD Comparison

Compare DRCT & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$2.30

Market Cap

1.9M

Sector

Technology

ML Signal

HOLD

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$2.40

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
AEMD
Founded
2018
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.1M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
DRCT
AEMD
Price
$2.30
$2.40
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$32.00
$15.00
AVG Volume (30 Days)
10.4K
115.5K
Earning Date
05-08-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$9.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.51
52 Week High
$7.21
$5.89

Technical Indicators

Market Signals
Indicator
DRCT
AEMD
Relative Strength Index (RSI) N/A 61.50
Support Level N/A $2.44
Resistance Level N/A $3.11
Average True Range (ATR) 0.00 0.20
MACD 0.00 -0.06
Stochastic Oscillator 0.00 11.39

Price Performance

Historical Comparison
DRCT
AEMD

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: